anmelden
FTSE All-Share
5.793,57
PKT
-20,91
PKT
-0,36
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 07.09.18 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 07.09.18 | AstraZeneca buy | Kepler Cheuvreux | |
| 06.09.18 | Vodafone Group buy | Citigroup Corp. | |
| 06.09.18 | GSK Hold | Deutsche Bank AG | |
| 06.09.18 | Lloyds Banking Group overweight | Barclays Capital | |
| 06.09.18 | Unilever Neutral | Goldman Sachs Group Inc. | |
| 06.09.18 | Unilever Neutral | Goldman Sachs Group Inc. | |
| 06.09.18 | Diageo buy | Goldman Sachs Group Inc. | |
| 06.09.18 | National Grid buy | HSBC | |
| 05.09.18 | BP overweight | Morgan Stanley | |
| 05.09.18 | Shell (ex Royal Dutch Shell) Equal-Weight | Morgan Stanley | |
| 05.09.18 | Barclays overweight | JP Morgan Chase & Co. | |
| 05.09.18 | Vodafone Group Outperform | Bernstein Research | |
| 04.09.18 | Unilever Neutral | Credit Suisse Group | |
| 04.09.18 | Diageo buy | Kepler Cheuvreux | |
| 04.09.18 | Imperial Brands Neutral | Goldman Sachs Group Inc. | |
| 04.09.18 | BAT buy | Goldman Sachs Group Inc. | |
| 04.09.18 | Barclays overweight | JP Morgan Chase & Co. | |
| 04.09.18 | Lloyds Banking Group overweight | JP Morgan Chase & Co. | |
| 04.09.18 | BAT overweight | JP Morgan Chase & Co. | |
| 04.09.18 | HSBC Neutral | JP Morgan Chase & Co. | |
| 04.09.18 | Lloyds Banking Group Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 03.09.18 | Imperial Brands Underperform | RBC Capital Markets | |
| 03.09.18 | BAT Underperform | RBC Capital Markets | |
| 31.08.18 | National Grid Neutral | Goldman Sachs Group Inc. | |
| 31.08.18 | Vodafone Group overweight | Barclays Capital | |
| 31.08.18 | Lloyds Banking Group buy | UBS AG | |
| 31.08.18 | Standard Chartered Neutral | UBS AG | |
| 31.08.18 | HSBC Neutral | UBS AG | |
| 31.08.18 | Vodafone Group buy | UBS AG | |
| 31.08.18 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 30.08.18 | Vodafone Group buy | CFRA | |
| 30.08.18 | Shell (ex Royal Dutch Shell) overweight | JP Morgan Chase & Co. | |
| 30.08.18 | BP overweight | JP Morgan Chase & Co. | |
| 30.08.18 | Vodafone Group overweight | Barclays Capital | |
| 30.08.18 | Vodafone Group Neutral | Merrill Lynch & Co., Inc. | |
| 30.08.18 | Prudential buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 30.08.18 | AstraZeneca Outperform | Credit Suisse Group | |
| 29.08.18 | Lloyds Banking Group overweight | JP Morgan Chase & Co. | |
| 29.08.18 | Prudential Neutral | JP Morgan Chase & Co. |
